متابعة
mervat hamed elhamamsy
mervat hamed elhamamsy
Lecturer in Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tanta , Egypt
بريد إلكتروني تم التحقق منه على pharm.tanta.edu.eg - الصفحة الرئيسية
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium Tuberculosis. Bioorg. Med, Chem., 15, 4552 – 4576
MHRI El-Hamamsy, AW Smith, AS Thompson, MD Threadgill
71*2007
Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach
HO Tawfik, A Petreni, CT Supuran, MH El-Hamamsy
European journal of medicinal chemistry 232, 114190, 2022
332022
1,4-Dihydropyridine Calcium Channel Blockers: Homology Modeling of the Receptor and Assessment of Structure Activity Relationship
TFEM Moataz A. Shaldam, Mervat H. Elhamamsy, Eman A. Esmat
ISRN Medicinal Chemistry 2014, 14, 2014
28*2014
Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors
HO Tawfik, TF El-Moselhy, NS El-Din, MH El-Hamamsy
Bioorganic & Medicinal Chemistry 27 (23), 115126, 2019
222019
Synthesis, evaluation and docking study of 1, 3, 5-triazine derivatives as cytotoxic agents against lung cancer
MF Balahaa, MH El-Hamamsyb, NAS El-Dinc, NA El-Mahdyd
Journal of Applied Pharmaceutical Science 6 (4), 028-045, 2016
222016
Design, synthesis, and molecular docking study of new monastrol analogues as kinesin spindle protein inhibitors
MH El‐Hamamsy, NA Sharafeldin, TF El‐Moselhy, HO Tawfik
Archiv der Pharmazie 353 (8), 2000060, 2020
152020
Dependence on linkers’ flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents
HO Tawfik, A Belal, MAS Abourehab, A Angeli, A Bonardi, CT Supuran, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 2765-2785, 2022
132022
Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX
AI Zain-Alabdeen, TF El-Moselhy, N Sharafeldin, A Angeli, CT Supuran, ...
Scientific Reports 12 (1), 16756, 2022
122022
New Genetic Bomb Trigger: Design, Synthesis, Molecular Dynamics Simulation, and Biological Evaluation of Novel BIBR1532-Related Analogs Targeting Telomerase against Non-Small …
HO Tawfik, AA El-Hamaky, EA El-Bastawissy, KA Shcherbakov, ...
Pharmaceuticals 15 (4), 481, 2022
122022
Synthesis, evaluation of pharmacological activity, and molecular docking of 1, 4-dihydropyridines as calcium antagonists
MA Shaldam, MH El-Hamamsy, DO Saleh, TF El-Moselhy
Chemical and Pharmaceutical Bulletin 64 (4), 297-304, 2016
72016
Discovery of new symmetrical and asymmetrical nitrile-containing 1,4-dihydropyridine derivatives as dual kinases and P-glycoprotein inhibitors: synthesis, in vitro assays, and …
MH Saad, TF El-Moselhy, N S, El-Din, ABM Mehany, A Belal, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 2489-2511, 2022
62022
Discovery of novel enasidenib analogues targeting inhibition of mutant isocitrate dehydrogenase 2 as antileukaemic agents
AF Khalil, TF El-Moselhy, EA El-Bastawissy, R Abdelhady, NS Younis, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2157411, 2023
52023
Accessing the anti-proliferating activity of tankyrase-2 inhibitors via 2d, 3d-QSAR and molecular docking: assessment of structure activity relationships
MH El-Hamamsy
Journal of Applied Pharmaceutical Science 7 (12), 014-027, 2017
42017
Factorial analysis optimization of memantine hydrochloride spectrofluorimetric quantitation via derivatization withoff-phthalaldehyde in the absence of thiol
MH El-Hamamsy
Journal of Innovations in Pharmaceutical and Biological Science4 (4), 176-184, 2017
42017
El-Din, NAESS Exploring the cytotoxicity of 1, 3, 5-triazines and triazine analogs against lung cancer by QSAR study using genetic function approximation
MF Balaha, MH El-Hamamsy
Pharma Chem 8 (3), 180-188, 2016
42016
Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFRWT, EGFRT790M, and EGFRL858R)
MG Abo Al-Hamd, HO Tawfik, O Abdullah, K Yamaguchi, M Sugiura, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2241674, 2023
32023
Corrigendum to" Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors"[Bioorg. Med. Chem. 27 (2019) 115126].
HO Tawfik, TF El-Moselhy, NS El-Din, MH El-Hamamsy
Bioorganic & medicinal chemistry 28 (2), 115255-115255, 2019
12019
Design, synthesis and biological evaluation of 1, 3, 5-triazine derivatives as potential inhibitors of dihydrofolate reductase
M El-Hamamsy, N El-Mahdy
Life Sci J 11 (11), 2014
12014
Potential antimycobacterial agent targeting dihydrofolate reductase
MHRI El-Hamamsy
PQDT-UK & Ireland, 2005
12005
Design and synthesis of quinazolin-4-one derivatives as potential anticancer agents and investigation of their interaction with RecQ helicases
HS Haggag, SM Aboukhatwa, MS Nafie, A Paul, N Sharafeldin, AW Oliver, ...
Bioorganic Chemistry 144, 107086, 2024
2024
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20